Skip to main content
OpenTrials
Completed

NCT Number: NCT00279890

Topical Agent for Treatment of Red Skin

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rosacea Bilaterally Symmetric Red Skin on Cheeks Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Mayo Clinic

Scottsdale, Arizona, 55259, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Bilaterally symmetric red skin on cheeks Caucasian Age 18-60 years

Treatment and study plan

Topical SR-01

Drug

Primary outcomes

  1. Reduction of redness

Secondary outcomes

  1. Safety and tolerability

  2. Cosmetic acceptability

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Proof of Concept Trial:SR-01 for the Treatment of Rosacea

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Jan 20, 2006
Registry last updated
May 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.